Gastric Cancer Clinical Trials in Wroclaw
2 recruitingWroclaw, Poland
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
Gastroesophageal Junction AdenocarcinomaHER2-positive Gastric Cancer
AstraZeneca840 enrolled284 locationsNCT06764875
Recruiting
H. Pylori Screen-and-treat Study in a Population of Young Adults
Gastric CancerH.Pylori InfectionH Pylori Eradication+1 more
University of Latvia6,800 enrolled7 locationsNCT06275204